KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Hemopatch to Prevent Lymphatic Leak after Robotic Prostatectomy and Pelvic Lymph Node Dissection: A Randomized Controlled Trial.

Jeremy Yuen-Chun Teoh, Alex Qinyang Liu, Violet Wai-Fan Yuen, Franco Pui-Tak Lai, Steffi Kar-Kei Yuen, Samson Yun-Sang Chan, Julius Ho-Fai Wong, Joseph Kai-Man Li, Mandy Ho-Man Tam, Peter Ka-Fung Chiu, Samuel Chi-Hang Yee, Chi-Fai Ng

Cancers (Basel) 14(18) 4476

PMID36139636
PMCIDPMC9496659
DOI10.3390/cancers14184476
发表日期2022-09-23
摘要

摘要

This study investigates whether the application of Hemopatch, a novel hemostatic patch, could prevent lymphatic leak after robotic-assisted radical prostatectomy (RARP) and bilateral pelvic lymph node dissection (BPLND). This is a prospective, single-center, phase III randomized controlled trial investigating the efficacy of Hemopatch in preventing lymphatic leak after RARP and BPLND. Participants were randomized to receive RARP and BPLND, with or without the use of Hemopatch, with an allocation ratio of 1:1. The primary outcome is the total drain output volume. The secondary outcomes include blood loss, operative time, lymph node yield, duration of drainage, drain output per day, hospital stay, transfusion and 30-day complications. A total of 32 patients were recruited in the study. The Hemopatch group had a significantly lower median total drain output than the control group (35 mL vs. 180 mL, p = 0.022) and a significantly lower drain output volume per day compared to the control group (35 mL/day vs. 89 mL/day, p = 0.038). There was no significant difference in the other secondary outcomes. In conclusion, the application of Hemopatch in RARP and BPLND could reduce the total drain output volume and the drain output volume per day. The use of Hemopatch should be considered to prevent lymphatic leakage after RARP and BPLND.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。